Cargando…

“ILD” after COVID‐19 Infection: A Catalogue of Uncertainties

Detalles Bibliográficos
Autores principales:	Wells, Athol U., Devaraj, Anand, Desai, Sujal R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radiological Society of North America 2021
Materias:	Reviews and Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841875/ https://www.ncbi.nlm.nih.gov/pubmed/33502279 http://dx.doi.org/10.1148/radiol.2021204482

Ejemplares similares

Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics
por: Chua, Felix, et al.
Publicado: (2019)

Residual Lung Disease at 6-month Follow-up CT after COVID-19: Clinical Significance Is a Key Issue
por: Wells, Athol U, et al.
Publicado: (2021)

Serial Decline in Lung Volume Parameters on Computed Tomography (CT) Predicts Outcome in Idiopathic Pulmonary Fibrosis (IPF)
por: Robbie, Hasti, et al.
Publicado: (2022)

COVID‐19 related lung pathology: old patterns in new clothing?
por: Nicholson, Andrew G, et al.
Publicado: (2020)

Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis
por: Jacob, Joseph, et al.
Publicado: (2018)

“Any fool can make a rule and any fool will mind it”
por: Wells, Athol U.
Publicado: (2016)

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
por: Flaherty, Kevin R, et al.
Publicado: (2017)

CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge
por: Vijayakumar, Bavithra, et al.
Publicado: (2021)

Cataloguing guanidinoacetic acid content in nutritional supplements
por: Ostojic, Sergej M., et al.
Publicado: (2022)

Vaccination Uncertainties and COVID-19 Prospects in 2021
por: Wu, Peng, et al.
Publicado: (2021)

Uncertainty and COVID-19: how are we to respond?
por: Koffman, Jonathan, et al.
Publicado: (2020)

P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis
por: Nwankwo, Lisa, et al.
Publicado: (2022)

Home monitoring for patients with ILD and the COVID-19 pandemic
por: Nakshbandi, G, et al.
Publicado: (2020)

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Jee, Adelle S., et al.
Publicado: (2017)

Towards a catalogue of biodiversity databases: An ontological case study
por: Blair, Jarrett, et al.
Publicado: (2020)

Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality
por: Tsitoura, Eliza, et al.
Publicado: (2021)

The PH‐ILD Detection tool: External validation and use in patients with ILD
por: Parikh, Raj, et al.
Publicado: (2023)

COVID-19 and ESRD: Entering a New Era of Uncertainty
por: Valeri, Anthony
Publicado: (2020)

Tracking Validation of ILD
por: Lu, S.
Publicado: (2018)

ILD simulation model
por: Lu, S.
Publicado: (2018)

Front-end Electronics for the TPC in ILD
por: Hedberg, V, et al.
Publicado: (2015)

Palliative care for cancer patients with severe COVID-19: the challenge of uncertainty
por: Cheng, Hon Wai Benjamin
Publicado: (2020)

Natural variability in the disease course of SSc-ILD: implications for treatment
por: Vonk, Madelon C., et al.
Publicado: (2021)

The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD
por: Kolb, Martin, et al.
Publicado: (2022)

The design of the ILD forward region
por: Levy, A
Publicado: (2018)

(Selected) MDI Issues of ILD
por: Pöschl, Roman
Publicado: (2020)

ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF
por: Durheim, Michael T, et al.
Publicado: (2020)

Chest CT of Lung Injury 1 Year after COVID-19 Pneumonia: The CovILD Study
por: Luger, Anna K., et al.
Publicado: (2022)

Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
por: Yamakawa, Hideaki, et al.
Publicado: (2021)

Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry
por: Raghu, Ganesh, et al.
Publicado: (2016)

Reply to Sanfilippo et al. and to Caviedes et al.
por: Arachchillage, Deepa J., et al.
Publicado: (2021)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Children’s Interstitial and Diffuse Lung Diseases (ChILD) in 2020
por: Ferraro, Valentina Agnese, et al.
Publicado: (2020)

Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research
por: Ferreira da Silva, Renato, et al.
Publicado: (2023)

The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF) - practical implications
por: Wells, Athol U
Publicado: (2013)

Front-end electronics and readout system for the ILD TPC
por: Hedberg, V, et al.
Publicado: (2015)

Wresting SARS from Uncertainty
por: Lingappa, Jairam R., et al.
Publicado: (2004)

Calibration of the Scintillator Hadron Calorimeter of ILD
por: CALICE Collaboration
Publicado: (2009)

Navigational Bronchoscopy with Cryobiopsy for Diagnosis of ILD
por: Figueroa Rodriguez, Fernando, et al.
Publicado: (2022)

Moving from PF-ILD to PPF
por: Bhattacharyya, Parthasarathi
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b2dv98ftuqc5urk770u62r3pjj